Use access key #2 to skip to page content.
$76.88 4.09 (5.62%)
7/8/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View Ticker Page (GENZ)

Results 31 - 35 of 35 :   1234

Recs

0

Avatar meghanjack (84.41) Submitted: 8/27/07 6:35 PM : Outperform Start Price: $59.20 GENZ Score: 42.84

tolevamer!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar hendrikvanlaar (< 20) Submitted: 9/11/07 4:13 AM : Outperform Start Price: $63.29 GENZ Score: 34.49

lagging behind for no good reason

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar darb48824 (44.87) Submitted: 10/30/07 3:37 PM : Outperform Start Price: $74.90 GENZ Score: 19.54

Quietly turning into a monster. Will hit the high 80's in '08 IMO. Still a great buy.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar bclan13 (99.50) Submitted: 10/29/07 11:01 PM : Outperform Start Price: $73.30 GENZ Score: 21.99

I see accelerated drug development in Genzyme's near future; I love companies with relatively well developed therapeutic and diagnostics expertise, and the desire to codevelop products.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ihickman (< 20) Submitted: 7/08/08 2:57 PM : Outperform Start Price: $75.88 GENZ Score: 0.76

I love the amount of research and development this company has.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners